Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 2
1969 2
1971 1
1972 1
1975 1
1977 1
1978 1
1979 1
1981 2
1982 8
1983 2
1984 4
1986 2
1987 1
1988 4
1989 1
1990 12
1991 1
1992 1
1993 3
1994 2
1995 4
1996 1
1998 3
1999 2
2000 2
2002 1
2004 1
2005 1
2008 2
2009 3
2010 3
2011 1
2012 1
2013 10
2014 6
2015 5
2016 9
2017 9
2018 9
2019 4
2020 11
2021 17
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, Chia WN, Chen MI, Wang LF, Ooi EE, Kalimuddin S, Tambyah PA, Low JG, Tan YJ, Bertoletti A. Le Bert N, et al. Among authors: tan at. Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15. Nature. 2020. PMID: 32668444
SARS-CoV-2-specific T cells in infection and vaccination.
Bertoletti A, Le Bert N, Qui M, Tan AT. Bertoletti A, et al. Among authors: tan at. Cell Mol Immunol. 2021 Oct;18(10):2307-2312. doi: 10.1038/s41423-021-00743-3. Epub 2021 Sep 1. Cell Mol Immunol. 2021. PMID: 34471260 Free PMC article. Review.
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
Le Bert N, Clapham HE, Tan AT, Chia WN, Tham CYL, Lim JM, Kunasegaran K, Tan LWL, Dutertre CA, Shankar N, Lim JME, Sun LJ, Zahari M, Tun ZM, Kumar V, Lim BL, Lim SH, Chia A, Tan YJ, Tambyah PA, Kalimuddin S, Lye D, Low JGH, Wang LF, Wan WY, Hsu LY, Bertoletti A, Tam CC. Le Bert N, et al. Among authors: tan at. J Exp Med. 2021 May 3;218(5):e20202617. doi: 10.1084/jem.20202617. J Exp Med. 2021. PMID: 33646265 Free PMC article. Clinical Trial.
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals.
Lozano-Ojalvo D, Camara C, Lopez-Granados E, Nozal P, Del Pino-Molina L, Bravo-Gallego LY, Paz-Artal E, Pion M, Correa-Rocha R, Ortiz A, Lopez-Hoyos M, Iribarren ME, Portoles J, Rojo-Portoles MP, Ojeda G, Cervera I, Gonzalez-Perez M, Bodega-Mayor I, Montes-Casado M, Portoles P, Perez-Olmeda M, Oteo J, Sanchez-Tarjuelo R, Pothula V, Schwarz M, Brahmachary M, Tan AT, Le Bert N, Berin C, Bertoletti A, Guccione E, Ochando J. Lozano-Ojalvo D, et al. Among authors: tan at. Cell Rep. 2021 Aug 24;36(8):109570. doi: 10.1016/j.celrep.2021.109570. Epub 2021 Aug 4. Cell Rep. 2021. PMID: 34390647 Free PMC article.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Swadling L, Diniz MO, Schmidt NM, Amin OE, Chandran A, Shaw E, Pade C, Gibbons JM, Le Bert N, Tan AT, Jeffery-Smith A, Tan CCS, Tham CYL, Kucykowicz S, Aidoo-Micah G, Rosenheim J, Davies J, Johnson M, Jensen MP, Joy G, McCoy LE, Valdes AM, Chain BM, Goldblatt D, Altmann DM, Boyton RJ, Manisty C, Treibel TA, Moon JC; COVIDsortium Investigators, van Dorp L, Balloux F, McKnight Á, Noursadeghi M, Bertoletti A, Maini MK. Swadling L, et al. Among authors: tan at. Nature. 2022 Jan;601(7891):110-117. doi: 10.1038/s41586-021-04186-8. Epub 2021 Nov 10. Nature. 2022. PMID: 34758478 Free PMC article.
HBV as a target for CAR or TCR-T cell therapy.
Bertoletti A, Tan AT. Bertoletti A, et al. Among authors: tan at. Curr Opin Immunol. 2020 Oct;66:35-41. doi: 10.1016/j.coi.2020.04.003. Epub 2020 Apr 30. Curr Opin Immunol. 2020. PMID: 32361634 Review.
157 results